Escherichia coli were incubated in mouse whole blood ex vivo supplemented with b-lactam antibiotics that possessed preferential affinities for penicillin-binding proteins (PBPs). After 4 h, viable bacteria were undetectable in the presence of any of the 3 antibiotics tested, whereas significant increases in colony-forming units were detected in samples not treated with antibiotics. Differential levels of endotoxin in platelet-rich plasma were detected using the limulus amebocyte lysate assay, according to differential antibiotic affinities for the various PBPs. Levels of tumor necrosis factora (TNF-a) and interleukin-6 (IL-6) in antibiotic-treated cultures after 8 h of incubation correlated well with the levels of endotoxin at 4 h (r Å .96, P õ .0001 for TNF-a; r Å .91, P Å .0002 for IL-6). These data indicate that differential affinities of b-lactam antibiotics for PBPs affect both endotoxin and cytokine responses ex vivo in mouse blood and correlate with in vivo protective efficacy of these antibiotics in gram-negative experimental models.
Over the past several decades, in vitro and in vivo data from this phenomenon, these species often must be treated to make them sensitive to endotoxin, infection, or both. Most mouse many laboratories have provided compelling support for the concept that endotoxin derived from the gram-negative microbe and rat strains are intrinsically relatively resistant to the pathophysiologic effect of endotoxin. Because one of the ultimate may play a pivotal role in the pathogenesis of the sepsis syndrome [1, 2] . It has been increasingly appreciated that free, goals of these studies is to contribute to potential therapeutic intervention strategies for treatment of septic patients, the clininonmicrobe-associated endotoxin is significantly more biologically active than is endotoxin associated with the outer cell cal relevance of the findings has been considered within the framework of differential antibiotic-induced endotoxin release membrane of gram-negative microbes. Thus, the concept that the release of endotoxin, both in rate and extent, might be an during treatment of systemic gram-negative bacterial infection [9, 10] . However, to date, relatively few studies have directly important variable has been subject to experimental investigation [3] . Antibiotics, particularly those that act as inhibitors of addressed this question, at least in part because of the difficulty in designing well-controlled clinical studies [11] . The available cell wall biosynthesis, have been studied as potential variables that may influence endotoxin release. There is now an abunclinical evidence is nevertheless not inconsistent with the conclusion that, all other things being equal, antibiotic-induced dance of experimental data from in vitro and in vivo animal models that different cell wall -active antibiotics differ in their release of endotoxin may contribute to the pathophysiology of the sepsis syndrome [12, 13] . ability to cause endotoxin release from gram-negative microbes [4 -8] .
With regard to antibiotic-induced endotoxin release, much attention has been directed to cell wall -active b-lactam antibiAlthough analyses with experimental animal models (primarily mice and rats) have been used extensively to increase otics [4] . Variance in affinities of the individual antibiotics for penicillin-binding proteins (PBPs) exists even within a given our understanding of the in vivo physiologic significance of subclass, and PBPs affect bacterial growth, morphology, and lysis, resulting in different amounts of endotoxin being liberated from microbes. Imipenem is a subclass of carbapenem with 180 mL of trypticase soy broth in microtiter plates and plated the differential effects of these antibiotics. The ex vivo experionto MacConkey agar (Difco, Detroit) in duplicate. After overnight ments used human whole blood from both healthy people and incubation at 37ЊC, colony-forming units (cfu) were counted. The septic patients [16, 17] other animals on the basis of mechanism, it will be important MD) in accord with the manufacturer's instructions. The plasma to correlate data from experimental animal models with both was diluted 10-fold with pyrogen-free water and incubated at 70ЊC
in vitro and ex vivo experimental approaches.
for 5 min as a pretreatment before the LAL assay.
Here we report the results of an ex vivo study in which we
Interleukin-6 (IL-6) assay. We measured mouse IL-6 by an ELISA with a 15 pg/mL detection limit (PharMingen, San Diego), used whole blood from the same mouse strain that we used following the manufacturer's instructions. Plasma was diluted 5-previously for in vivo experiments [8] . We also correlated our fold for the assay.
findings with in vitro and in vivo data.
Tumor necrosis factor-a (TNF-a) assay. TNF-a was measured by a mouse ELISA kit (Genzyme, Cambridge, MA) with a 35 pg/mL detection limit. Again, we followed the manufacturer's
Materials and Methods
instructions. Plasma was diluted 5-fold for the assay. Mice. We used 10-to 12-week-old female CF-1 outbred mice Statistical analysis. For correlation analyses, we used Pear-(Harlan Sprague-Dawley, Indianapolis). Mice were housed 5 per son's correlation coefficient. Regression lines were made by the cage and allowed to rest §5 days prior to experimentation. method of least squares using StatView 4.5 (Abacus Concepts, Bacteria. E. coli O111:B4 (List Biological Laboratories, Berkeley, CA). P õ .05 (Fisher's r to z) was considered statistically Campbell, CA) was used throughout the experiments. Bacteria significant. were cultured and prepared exactly as described by Bucklin and Morrison [8] .
Antibiotics. Bacterial recovery. Our experiments were designed to asaccording to manufacturers' instructions and stored at 070ЊC. The sess the relative efficacy of 3 antibiotics -imipenem, mero-
MICs for E. coli O111:B4 were determined as previously described penem, and ceftazidime -in killing E. coli in whole mouse [8] . They were 0.25 mg/mL for both ceftazidime and imipenem blood and the consequences of bacterial killing on endotoxin and 0.03 mg/mL for meropenem.
release and induction of cytokine secretion. For these studies,
Whole blood stimulation. Mice were anesthetized intraperitoneally with 60 mg/g of body weight with pentobarbital sodium E. coli at 10 5 cfu/mL were incubated in 1.0 mL of whole were assessed for cfu of viable organisms and for endotoxin Aliquots of 0.9 mL of blood were dispensed into borosilicate glass and the cytokines TNF-a and IL-6 as described in Materials tubes that had been baked at 230ЊC overnight before use. After and Methods.
samples were warmed to 37ЊC, 0.05 mL of log-phase bacterial
As shown by the data in figure 1A , the viable bacteria in blood was centrifuged, and endotoxin levels in platelet-rich Quantitation of bacterial killing. Blood (20 mL) was collected from each tube at 4 or 8 h of incubation and diluted 10-fold serially plasma were assessed. As shown in figure 1B , in control cul- tures not treated with antibiotics, endotoxin levels increased toxin levels in cultures incubated with meropenem or ceftazidime were much higher than in controls or in cultures treated during the 8-h observation period. In contrast to these results, the levels of endotoxin detected in cultures treated with the with imipenem, even 4 h after treatment. Of interest, the endotoxin levels in cultures treated with meropenem at 51 the various antibiotics were strikingly different at 4 and 8 h of incubation, depending on the MIC. At 51 the MIC, the endo-MIC at both time points were higher than those treated with ceftazidime. At 501 the MIC, the endotoxin levels of ceftazidbelow, we excluded nonantibiotic-treated cultures from analysis.) On the basis of the postulated time lag between the ime-and meropenem-treated cultures were similar to those of controls at 4 h but significantly lower than seen in controls 8 release of endotoxin and production of cytokines, correlation analyses were sought between endotoxin levels at 4 h of h after treatment. Again, imipenem-treated cultures had the lowest endotoxin levels. incubation and cytokine levels at 8 h of incubation. A significant correlation among antibiotic-treated cultures was de-IL-6 levels. We anticipated that the released endotoxin (and to a lesser extent the microbe-associated lipopolysactected between the levels of endotoxin and IL-6 (figure 2: r Å .91, n Å 9, P Å .0002), endotoxin and TNF-a (figure 2: charide [LPS]) would induce the synthesis and secretion of cytokines in the white blood cells present in the ex vivo r Å .96, n Å 9, P õ .0001), and IL-6 and TNF-a (figure 3: r Å .90, n Å 9, P Å .0004). cultures. As shown in figure 1C , IL-6 levels in most cultures incubated with bacteria alone increased only modestly during the 8-h observation period. At both 501 and 51 the Discussion MIC, the IL-6 levels were substantially higher in cultures treated with meropenem or ceftazidime than observed in All 3 b-lactam antibiotics inhibited bacterial growth during the first 8 h of incubation relative to control nonantibithose treated with imipenem, essentially paralleling the endotoxin levels shown in figure 1B. Endotoxin levels with otic-treated cultures, although at 51 the MIC, the ceftazidime appeared to be somewhat more bactericidal than either meropenem were higher than those from ceftazidime at 51 the MIC. The levels in cultures inoculated with antibiotics imipenem or meropenem. Definitive conclusions are difficult because of the propensity of ceftazidime to cause filament alone were Ç560 -680 pg/mL. TNF-a levels. As shown in figure 1D , TNF-a was detected formation that may be misleading with respect to precise quantitation of cfu. Of importance, the levels of endotoxin, only after 8 h of incubation in all of the cultures. In the absence of antibiotics, only very low minimally detectable levels of IL-6, and TNF-a varied significantly, depending on antibiotic: The lowest levels of endotoxin and cytokines were TNF-a were observed. At both antibiotic concentrations (501 and 51 the MIC), the levels of TNF-a in cultures with meroobserved with imipenem. At both 51 and 501 the MICs, ceftazidime, a cephalosporin, penem or ceftazidime were again significantly higher than those observed with imipenem treatment. At 51 the MIC, the level and PBP-1 and -3 inhibitors of E. coli induced Ç3 times as much endotoxin as imipenem, a carbapenem, and PBP-1 and with meropenem was much higher than with ceftazidime. The levels in cultures inoculated with antibiotics alone were below -2 inhibitor [15] . Of interest, meropenem (a carbapenem known to inhibit the growth of E. coli by binding to PBP-2 and -3) the detection limit.
Correlation analysis. The general concept that might exinduced Ç3 times (at 501 the MIC) and 4 times (at 51 the MIC) more endotoxin than did imipenem. Jackson and Kropp plain these observations is that endotoxin released from E. coli by the action of the antibiotics stimulates white blood [4] reported that at high meropenem concentrations (101 the MIC), the PBP-2 enzyme was primarily inhibited, whereas cells to secrete TNF-a and IL-6. As a consequence, it would be predicted that cytokine levels should correlate with levels PBP-3 was inhibited more effectively at lower or sub-MIC concentrations (0.25 -2.01 the MIC) in Pseudomonas aerugiof free endotoxin generated by the antibiotic treatment. We therefore assessed whether such a correlation exists by comnosa. The same underlying mechanism may serve to explain the results described here; however, until additional studies are paring cytokine levels with measured endotoxin levels in all of the antibiotic-treated cultures. (For reasons discussed done, these findings cannot be extrapolated to all gram-negative We previously reported in vivo data using the identical strain of mice and classes of antibiotics as used here [8] .
In that study, imipenem showed a much higher protective efficacy than did either ceftazidime or meropenem at doses recommended for clinical use and equivalency in the inhibitory effects on bacterial growth. Considering that meropenem is the same subclass as imipenem but also has an affinity for PBP-3 similar to that of ceftazidime, the present ex vivo data support the concept that higher mortality in experimental models of E. coli sepsis may result from differential levels of endotoxin release induced by antibiotics with differential modes of action.
Regarding potential cellular sources of cytokine produc- role in the regulation of multiple host defense during sepsis [22] . In our ex vivo system, the precise origin of cytokines is not clear. microorganisms. In addition, since recent studies from our lab-
The outcome of septic deterioration is complicated, and a oratory showed that different clinical isolates of gram-negative subtle balance between microbial factors and the immunoorganisms have LPSs that differ significantly in biological pologic responsiveness of the host may be critical. Neverthetency [18], the effect of differential LPS release may not be less, our ex vivo system using mouse whole blood is useful reflected in cytokine generation.
for analysis to clarify what may transpire during treatment The levels of IL-6 and TNF-a, both well-known proinwith antibiotics in vivo during sepsis and for interpreting flammatory cytokines in sepsis [19] , were significantly correaccumulating in vitro and in vivo data by facilitating extrapolated with the level of endotoxin in antibiotic-treated cultures lation with each other. Collectively, our data provide clear but not with bacterial growth indicated by cfu. Of potential evidence that, at least in this relatively straightforward enviimportance, cytokine levels (especially between antibioticronment, antibiotics may affect the bacterial endotoxin level treated groups and untreated controls) did not always parallel according to differential affinities for PBPs and correspondthose of endotoxin. For example, relatively high levels of ing immunologic responses, such as TNF-a and IL-6 producendotoxin were observed after 8 h in the control nonantibition. otic-treated cultures; however, this was not accompanied by significant production of either IL-6 or TNF-a. These find-
